The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Pin to quick picksAlliance Pharma Share News (APH)

Share Price Information for Alliance Pharma (APH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 32.00
Bid: 31.95
Ask: 32.00
Change: -1.10 (-3.32%)
Spread: 0.05 (0.156%)
Open: 34.50
High: 34.50
Low: 31.00
Prev. Close: 33.10
APH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: Bank of America says buy Experian and Intertek

Tue, 22nd Mar 2022 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

----------

FTSE 100

----------

Bank of America reinitiates Experian with 'buy' - price target 3,700 pence

----------

Bank of America reinitiates Intertek with 'buy' - price target 6,200 pence

----------

UBS cuts Flutter price target to 15,000 (16,350) pence - 'buy'

----------

Kepler Cheuvreux raises Pearson price target to 750 (725) pence - 'hold'

----------

Kepler Cheuvreux cuts Rolls-Royce price target to 129 (165) pence - 'buy'

----------

SocGen cuts GlaxoSmithKline price target to 2,115 (2,175) pence - 'buy'

----------

SocGen cuts Diageo price target to 4,250 (4,500) pence - 'buy'

----------

SocGen cuts Coca-Cola HBC price target to 1,845 (2,255) pence - 'hold'

----------

Credit Suisse cuts Kingfisher price target to 375 (425) pence - 'outperform'

----------

Barclays cuts London Stock Exchange price target to 9,200 (9,500) pence - 'overweight'

----------

Goldman Sachs cuts Burberry price target to 2,400 (2,560) pence - 'buy'

----------

JPMorgan cuts DCC price target to 7,000 (8,349) pence - 'overweight'

----------

FTSE 250

----------

UBS cuts National Express price target to 330 (350) pence - 'buy'

----------

Jefferies raises Softcat price target to 2,350 (2,310) pence - 'buy'

----------

Panmure raises Bodycote to 'hold' ('sell') - target 671 (676) pence

----------

Berenberg raises Big Yellow price target to 1,500 (1,140) pence - 'hold'

----------

Berenberg raises Safestore price target to 1,280 (970) pence - 'hold'

----------

Barclays cuts Network International target to 340 (440) pence - 'overweight'

----------

JPMorgan cuts Diploma to 'underweight' (neutral) - price target 2,500 (2,950) pence

----------

Jefferies starts Lancashire Holdings with 'buy' - price target 500 pence

----------

Jefferies raises Harbour Energy price target to 520 (480) pence - 'buy'

----------

SMALL CAP

----------

RBC raises Alliance Pharma price target to 130 (121) pence - 'outperform'

----------

Credit Suisse cuts S4 Capital price target to 685 (830) pence - 'outperform'

----------

Barclays cuts Wise price target to 745 (895) pence - 'equal weight'

----------

Bernstein raises Ryanair to 'outperform' (market-perform) - price target 16.80 EUR

----------

Goldman Sachs cuts Deliveroo price target to 320 (430) pence - 'buy'

----------

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
21 Jul 2020 10:24

Alliance Pharma revenues hit by Covid-19 in H1

(Sharecast News) - Healthcare group Alliance Pharma said on Tuesday that first-half revenues had been impacted by the Covid-19 pandemic, principally in its prescription medicines business.

Read more
28 Jun 2020 10:26

DIRECTOR DEALINGS: Alliance Pharma Chair Buys GBP100,000 In Shares

DIRECTOR DEALINGS: Alliance Pharma Chair Buys GBP100,000 In Shares

Read more
18 May 2020 10:51

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

UK TRADING UPDATE SUMMARY: Catenae Readies "Covid-19 Passport"

Read more
11 May 2020 16:03

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
7 Apr 2020 13:13

Alliance Pharma Withdraws Final Dividend Despite Strong 2019 Results

Alliance Pharma Withdraws Final Dividend Despite Strong 2019 Results

Read more
31 Mar 2020 16:01

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
24 Mar 2020 15:50

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
23 Mar 2020 18:12

Multiple UK Companies Warn On Covid-19 With Dividends Suffering

Multiple UK Companies Warn On Covid-19 With Dividends Suffering

Read more
17 Mar 2020 16:03

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Jan 2020 11:32

Alliance Pharma lowers net debt after "strong" revenue growth in 2019

(Sharecast News) - International healthcare group Alliance Pharma said it had recorded some strong revenue growth in 2019 on Wednesday as well as a rapid reduction in net debt.

Read more
22 Jan 2020 10:54

Alliance Pharma Annual Revenue Rises On Strong Product Performances

Alliance Pharma Annual Revenue Rises On Strong Product Performances

Read more
3 Jan 2020 15:57

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
12 Dec 2019 16:11

UK Dividends Calendar - Next 7 Days

UK Dividends Calendar - Next 7 Days

Read more
27 Nov 2019 15:00

Alliance Pharma handing back 'Xonvea' rights to Duchesnay

(Sharecast News) - Alliance Pharma has reached agreement with Duchesnay of Canada to return the UK and EU licensing rights to 'Xonvea', a prescription medicine for the treatment of nausea and vomiting of pregnancy where conservative management has failed, it announced on Wednesday.

Read more
27 Nov 2019 12:33

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Alliance Pharma Exits Xonvea Licensing Deal Amid Slow Sales Uptake

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.